ABT vs ISPOW · P/E 25, rev $44.33B vs rev $279.9M
Abbott Laboratories (ABT) versus Thayer Ventures Acquisition Corporation (ISPOW) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Thayer Ventures Acquisition Corporation (ISPOW) is a travel services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ISPOW revenue for 2024-12-31 was $279.9M. Net income was -$5.4M. Revenue was down 15.0% from 2023-12-31 to 2024-12-31.
ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Not investment advice. Open the ABT and ISPOW stock pages for the full models.
Not investment advice.